Stevens-Johnson Syndrome Associated with Mogamulizumab-induced Deficiency of Regulatory T cells in an Adult T-cell Leukaemia Patient

Acta Derm Venereol. 2015 May;95(5):606-7. doi: 10.2340/00015555-2027.

Authors

Tetsuya Honda¹, Masakatsu Hishizawa, Tatsuki R Kataoka, Katsuyuki Ohmori, Akifumi Takaori-Kondo, Yoshiki Miyachi, Kenji Kabashima

Affiliation

¹ Department of Dermatology, Kyoto University Graduate School of Medicine, Sho-goin Kawara-cho 54, Kyoto, 606-8507, Japan.

PMID: 25424342
DOI: 10.2340/00015555-2027

No abstract available

Publication types

Case Reports

MeSH terms

Adrenal Cortex Hormones / therapeutic use*
Antibodies, Monoclonal, Humanized / adverse effects*
Antibodies, Monoclonal, Humanized / therapeutic use
Biopsy, Needle
Flow Cytometry
Follow-Up Studies
Humans
Immunohistochemistry
Leukemia-Lymphoma, Adult T-Cell / drug therapy*
Leukemia-Lymphoma, Adult T-Cell / pathology*
Male
Middle Aged
Mouth Mucosa / drug effects
Mouth Mucosa / pathology
Neoplasm Invasiveness / pathology
Neoplasm Staging
Risk Assessment
Stevens-Johnson Syndrome / etiology*
Stevens-Johnson Syndrome / pathology
T-Lymphocytes, Regulatory / cytology
T-Lymphocytes, Regulatory / drug effects*
Treatment Outcome
Withholding Treatment

Substances

Adrenal Cortex Hormones
Antibodies, Monoclonal, Humanized
mogamulizumab